Enovis Corp Net Income (Loss) Attributable to Noncontrolling Interest
Enovis Corp (ENOV) reported Net Income (Loss) Attributable to Noncontrolling Interest of $1.23 million for the 3-month period ending 2022-04-01, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2022-05-10
- Enovis Corp net income (loss) attributable to noncontrolling interest for the quarter ending 2022-04-01 was $1.23M, a 5.75% increase year-over-year.
- Enovis Corp net income (loss) attributable to noncontrolling interest for the quarter ending 2021-12-31 was $1.39M, a 53.49% increase year-over-year.
- Enovis Corp net income (loss) attributable to noncontrolling interest for the quarter ending 2021-10-01 was $1.01M, a 27.88% increase year-over-year.
- Enovis Corp net income (loss) attributable to noncontrolling interest for the quarter ending 2021-07-02 was $1.06M, a 148.24% increase year-over-year.
- Enovis Corp net income (loss) attributable to noncontrolling interest for fiscal 2021 was $4.62M, a 46.88% increase from fiscal 2020.
- Enovis Corp net income (loss) attributable to noncontrolling interest for fiscal 2020 was $3.15M, a 70.04% decline from fiscal 2019.
- Enovis Corp net income (loss) attributable to noncontrolling interest for fiscal 2019 was $10.50M, a 26.46% decline from fiscal 2018.
- Enovis Corp net income (loss) attributable to noncontrolling interest for fiscal 2018 was $14.28M, a 22.48% decline from fiscal 2017.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-04-01 | $1.23M 10-Q · filed 2022-05-10 | $2.62M derived: sum of 2 quarters · filed 2022-05-10 | $3.63M derived: sum of 3 quarters · filed 2022-05-10 | $4.69M derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $2.40M derived: sum of 2 quarters · filed 2022-02-22 | $3.46M derived: sum of 3 quarters · filed 2022-02-22 | $4.62M 10-K · filed 2022-02-22 |
| 2021-10-01 | $1.01M 10-Q · filed 2021-11-04 | $2.07M derived: sum of 2 quarters · filed 2021-11-04 | $3.23M 10-Q · filed 2021-11-04 | $4.14M derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-07-02 | $1.06M 10-Q · filed 2021-07-28 | $2.23M 10-Q · filed 2021-07-28 | $3.13M derived: sum of 3 quarters · filed 2022-05-10 | $3.92M derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-04-02 | $1.17M 10-Q · filed 2022-05-10 | $2.07M derived: sum of 2 quarters · filed 2022-05-10 | $2.86M derived: sum of 3 quarters · filed 2022-05-10 | $3.29M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.69M derived: sum of 2 quarters · filed 2022-02-22 | $2.12M derived: sum of 3 quarters · filed 2022-02-22 | $3.15M 10-K · filed 2022-02-22 |
| 2020-10-02 | $789.00K 10-Q · filed 2021-11-04 | $1.22M derived: sum of 2 quarters · filed 2021-11-04 | $2.24M 10-Q · filed 2021-11-04 | $3.77M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-07-03 | $427.00K 10-Q · filed 2021-07-28 | $1.45M 10-Q · filed 2021-07-28 | $2.98M derived: sum of 3 quarters · filed 2022-02-22 | $5.30M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-04-03 | $1.03M 10-Q · filed 2021-04-29 | $2.56M derived: sum of 2 quarters · filed 2022-02-22 | $4.88M derived: sum of 3 quarters · filed 2022-02-22 | $7.51M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $3.85M derived: sum of 2 quarters · filed 2022-02-22 | $6.48M derived: sum of 3 quarters · filed 2022-02-22 | $10.50M 10-K · filed 2022-02-22 |
| 2019-09-27 | $2.32M 10-Q · filed 2020-10-29 | $4.95M derived: sum of 2 quarters · filed 2020-10-29 | $8.97M 10-Q · filed 2020-10-29 | $11.53M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-28 | $2.63M 10-Q · filed 2020-08-06 | $6.65M 10-Q · filed 2020-08-06 | $9.21M derived: sum of 3 quarters · filed 2021-02-18 | $13.10M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-29 | $4.02M 10-Q · filed 2020-05-07 | $6.58M derived: sum of 2 quarters · filed 2021-02-18 | $10.47M derived: sum of 3 quarters · filed 2021-02-18 | $13.79M derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $6.45M derived: sum of 2 quarters · filed 2021-02-18 | $9.77M derived: sum of 3 quarters · filed 2021-02-18 | $14.28M 10-K · filed 2021-02-18 |
| 2018-09-28 | $3.89M 10-Q · filed 2019-10-31 | $7.21M derived: sum of 2 quarters · filed 2019-10-31 | $11.72M 10-Q · filed 2019-10-31 | |
| 2018-06-29 | $3.32M 10-Q · filed 2019-08-06 | $7.83M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $4.51M 10-Q · filed 2018-05-03 | |||
| 2018-03-30 | $4.51M 10-Q · filed 2019-05-08 | $9.06M derived: sum of 2 quarters · filed 2020-02-24 | $14.90M derived: sum of 3 quarters · filed 2020-02-24 | $19.98M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $10.39M derived: sum of 2 quarters · filed 2020-02-24 | $15.47M derived: sum of 3 quarters · filed 2020-02-24 | $18.42M 10-K · filed 2020-02-24 |
| 2017-09-29 | $5.84M 10-Q · filed 2018-10-25 | $10.92M derived: sum of 2 quarters · filed 2018-10-25 | $13.87M 10-Q · filed 2018-10-25 | $18.91M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-06-30 | $5.08M 10-Q · filed 2018-08-06 | $8.03M 10-Q · filed 2018-08-06 | $13.07M derived: sum of 3 quarters · filed 2019-02-21 | $17.30M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-03-31 | $2.94M 10-Q · filed 2018-05-03 | $7.99M derived: sum of 2 quarters · filed 2019-02-21 | $12.22M derived: sum of 3 quarters · filed 2019-02-21 | $16.43M derived: sum of 4 quarters · filed 2019-02-21 |
| 2016-12-31 | $5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $9.28M derived: sum of 2 quarters · filed 2019-02-21 | $13.48M derived: sum of 3 quarters · filed 2019-02-21 | $17.08M 10-K · filed 2019-02-21 |
| 2016-09-30 | $4.23M 10-Q · filed 2017-11-06 | $8.44M derived: sum of 2 quarters · filed 2017-11-06 | $12.03M 10-Q · filed 2017-11-06 | $16.36M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-07-01 | $4.21M 10-Q · filed 2017-07-28 | $7.80M 10-Q · filed 2017-07-28 | $12.14M derived: sum of 3 quarters · filed 2018-02-16 | $17.32M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-04-01 | $3.60M 10-Q · filed 2017-05-05 | $7.93M derived: sum of 2 quarters · filed 2018-02-16 | $13.11M derived: sum of 3 quarters · filed 2018-02-16 | $18.82M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $9.52M derived: sum of 2 quarters · filed 2018-02-16 | $15.22M derived: sum of 3 quarters · filed 2018-02-16 | $19.44M 10-K · filed 2018-02-16 |
| 2015-09-25 | $5.19M 10-Q · filed 2016-10-27 | $10.89M derived: sum of 2 quarters · filed 2016-10-27 | $15.11M 10-Q · filed 2016-10-27 | $20.76M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-26 | $5.70M 10-Q · filed 2016-07-28 | $9.92M 10-Q · filed 2016-07-28 | $15.58M derived: sum of 3 quarters · filed 2017-02-14 | $23.49M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-27 | $4.22M 10-Q · filed 2016-05-03 | $9.87M derived: sum of 2 quarters · filed 2017-02-14 | $17.79M derived: sum of 3 quarters · filed 2017-02-14 | $24.35M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $13.57M derived: sum of 2 quarters · filed 2017-02-14 | $20.13M derived: sum of 3 quarters · filed 2017-02-14 | $28.18M 10-K · filed 2017-02-14 |
| 2014-09-26 | $7.91M 10-Q · filed 2015-10-22 | $14.47M derived: sum of 2 quarters · filed 2015-10-22 | $22.52M 10-Q · filed 2015-10-22 | $29.59M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-06-27 | $6.56M 10-Q · filed 2015-07-23 | $14.61M 10-Q · filed 2015-07-23 | $21.67M derived: sum of 3 quarters · filed 2016-02-16 | $31.67M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-03-28 | $8.05M 10-Q · filed 2015-04-23 | $15.11M derived: sum of 2 quarters · filed 2016-02-16 | $25.11M derived: sum of 3 quarters · filed 2016-02-16 | $33.92M derived: sum of 4 quarters · filed 2016-02-16 |
| 2013-12-31 | $7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $17.07M derived: sum of 2 quarters · filed 2016-02-16 | $25.88M derived: sum of 3 quarters · filed 2016-02-16 | $30.52M 10-K · filed 2016-02-16 |
| 2013-09-27 | $10.00M 10-Q · filed 2014-10-23 | $18.81M derived: sum of 2 quarters · filed 2014-10-23 | $23.45M 10-Q · filed 2014-10-23 | $28.78M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-28 | $8.81M 10-Q · filed 2014-07-25 | $13.45M 10-Q · filed 2014-07-25 | $18.78M derived: sum of 3 quarters · filed 2015-02-17 | $24.18M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-29 | $4.64M 10-Q · filed 2014-04-24 | $9.97M derived: sum of 2 quarters · filed 2015-02-17 | $15.38M derived: sum of 3 quarters · filed 2015-02-17 | $21.64M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $5.33M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $10.73M derived: sum of 2 quarters · filed 2015-02-17 | $17.00M derived: sum of 3 quarters · filed 2015-02-17 | $22.14M 10-K · filed 2015-02-17 |
| 2012-09-28 | $5.41M 10-Q · filed 2013-10-24 | $11.67M derived: sum of 2 quarters · filed 2013-10-24 | $16.81M 10-Q · filed 2013-10-24 | |
| 2012-06-29 | $6.27M 10-Q · filed 2013-07-25 | $11.40M 10-Q · filed 2013-07-25 | ||
| 2012-03-30 | $5.14M 10-Q · filed 2013-04-25 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-12 | |||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-31 | $0.00 derived: sum of 2 quarters · filed 2012-10-31 | $0.00 10-Q · filed 2012-10-31 | |
| 2011-07-01 | $0.00 10-Q · filed 2012-08-07 | $0.00 10-Q · filed 2012-08-07 | ||
| 2010-12-31 | $0.00 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |